Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/25 20:26 | 1/6/25 | DNLI | Health | BioPrd | Biological Products, (No Diag | Ho Carole | CA | O | Chief Me | 4 | S.m | -985 | 22.31 | 0 | -44 | 384 | D | |||||||||||||||
1/8/25 20:25 | 1/6/25 | DNLI | Health | BioPrd | Biological Products, (No Diag | Schuth Alexander O. | CA | O | COFO,Sec | 5 | S.dm | -1,428 | 22.25 | 0 | -64 | 768 | D | |||||||||||||||
1/8/25 20:24 | 1/6/25 | DNLI | Health | BioPrd | Biological Products, (No Diag | Watts Ryan J. | CA | DO | P,CEO | 4 | S.dm | -2,078 | 23.41 | 0 | -89 | 2,481 | D | |||||||||||||||
1/8/25 20:23 | 1/7/25 | DNLI | Health | BioPrd | Biological Products, (No Diag | Krognes Steve E. | CA | D | 7 | S.m | -4,211 | 22.05 | 0 | -191 | 990 | D | ||||||||||||||||
1/3/25 16:13 | 1/2/25 | DNLI | Health | BioPrd | Biological Products, (No Diag | Sato Vicki L | CA | D | 10 | S | -483 | 22.96 | 0 | -21 | 121 | D | ||||||||||||||||
11/13/24 16:18 | 11/11/24 | DNLI | Health | BioPrd | Biological Products, (No Diag | Schenkein David P | CA | D | 1 | S.d | -1,933 | 32.51 | 0 | -59 | 67 | D | ||||||||||||||||
6/10/24 20:06 | 6/6/24 | DNLI | Health | BioPrd | Biological Products, (No Diag | Cook Jennifer E. | CA | D | 1 | S | -32 | 21.73 | 0 | -1 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |